Vicky Makker

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 31

Top Topics

Endometrial Cancer

Body Mass Index

Epidermal Growth Factor Receptor

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Journal for immunotherapy of cancer

medRxiv : the preprint server for health sciences

Journal of gynecologic oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Vicky Makker, Matthew H Taylor, Carol Aghajanian, Allen L Cohn, Marcia S Brose, Christopher Di Simone, Zhu Alexander Cao, Leah Suttner, Andrey Loboda, Razvan Cristescu, Petar Jelinic, Robert Orlowski, Lea Dutta, Junji Matsui, Corina E Dutcus, Yukinori Minoshima, Mark J Messing
Evaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: results from Study 111/KEYNOTE-146. Journal for immunotherapy of cancer 12 (1) (2024)
Vicky Makker, Matthew H Taylor, Carol Aghajanian, Allen L Cohn, Marcia S Brose, Christopher Di Simone, Zhu Alexander Cao, Leah Suttner, Andrey Loboda, Razvan Cristescu, Petar Jelinic, Robert Orlowski, Lea Dutta, Junji Matsui, Corina E Dutcus, Yukinori Minoshima, Mark J Messing
Evaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: results from Study 111/KEYNOTE-146. Journal for immunotherapy of cancer 12 (1) (2024)
Ana Oaknin, Jung-Yun Lee, Vicky Makker, Do Youn Oh, Susana Banerjee, Antonio Gonzáles Martin, Kyung Hae Jung, Iwona Lugowska, Luis Manso, Aránzazu Manzano Fernández, Bohuslav Melichar, Salvatore Siena, Daniil Stroyakovskiy, Anitra Fielding, Soham Puvvada, Ann Smith, Funda Meric-Bernstam
Efficacy of Trastuzumab Deruxtecan in HER2-Expressing Solid Tumors by Enrollment HER2 IHC Status: Post Hoc Analysis of DESTINY-PanTumor02. Advances in therapy (2024)
Vicky Makker, Matthew H Taylor, Carol Aghajanian, Allen L Cohn, Marcia S Brose, Christopher Di Simone, Zhu Alexander Cao, Leah Suttner, Andrey Loboda, Razvan Cristescu, Petar Jelinic, Robert Orlowski, Lea Dutta, Junji Matsui, Corina E Dutcus, Yukinori Minoshima, Mark J Messing
Evaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: results from Study 111/KEYNOTE-146. Journal for immunotherapy of cancer 12 (1) (2024)
Nicolás Gómez-Banoy, Eduardo Ortiz, Caroline S Jiang, Christian Dagher, Carlo Sevilla, Jeffrey Girshman, Andrew Pagano, Andrew J Plodkowski, William A Zammarrelli, Jennifer J Mueller, Carol Aghajanian, Jorge S Reis-Filho, Vicky Makker, Paul Cohen, Juan C Osorio
Body mass index and adiposity influence responses to immune checkpoint inhibition in endometrial cancer. medRxiv : the preprint server for health sciences (2024)
Vicky Makker, Matthew H Taylor, Carol Aghajanian, Allen L Cohn, Marcia S Brose, Christopher Di Simone, Zhu Alexander Cao, Leah Suttner, Andrey Loboda, Razvan Cristescu, Petar Jelinic, Robert Orlowski, Lea Dutta, Junji Matsui, Corina E Dutcus, Yukinori Minoshima, Mark J Messing
Evaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: results from Study 111/KEYNOTE-146. Journal for immunotherapy of cancer 12 (1) (2024)
Nicolás Gómez-Banoy, Eduardo Ortiz, Caroline S Jiang, Christian Dagher, Carlo Sevilla, Jeffrey Girshman, Andrew Pagano, Andrew J Plodkowski, William A Zammarrelli, Jennifer J Mueller, Carol Aghajanian, Jorge S Reis-Filho, Vicky Makker, Paul Cohen, Juan C Osorio
Body mass index and adiposity influence responses to immune checkpoint inhibition in endometrial cancer. medRxiv : the preprint server for health sciences (2024)
Vicky Makker, Matthew H Taylor, Carol Aghajanian, Allen L Cohn, Marcia S Brose, Christopher Di Simone, Zhu Alexander Cao, Leah Suttner, Andrey Loboda, Razvan Cristescu, Petar Jelinic, Robert Orlowski, Lea Dutta, Junji Matsui, Corina E Dutcus, Yukinori Minoshima, Mark J Messing
Evaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: results from Study 111/KEYNOTE-146. Journal for immunotherapy of cancer 12 (1) (2024)
Kan Yonemori, Keiichi Fujiwara, Kosei Hasegawa, Mayu Yunokawa, Kimio Ushijma, Shiro Suzuki, Ayumi Shikama, Shinichiro Minobe, Tomoka Usami, Jae-Weon Kim, Byoung Gie Kim, Peng-Hui Wang, Ting-Chang Chang, Keiko Yamamoto, Shirong Han, Jodi-Ann Mckenzie, Robert J Orlowski, Takuma Miura, Vicky Makker, Yong Man Kim
Analysis of East Asia subgroup in Study 309/KEYNOTE-775: lenvatinib plus pembrolizumab versus treatment of physician's choice chemotherapy in patients with previously treated advanced or recurrent endometrial cancer. Journal of gynecologic oncology 35 (2) (2024)
Kan Yonemori, Keiichi Fujiwara, Kosei Hasegawa, Mayu Yunokawa, Kimio Ushijma, Shiro Suzuki, Ayumi Shikama, Shinichiro Minobe, Tomoka Usami, Jae-Weon Kim, Byoung Gie Kim, Peng-Hui Wang, Ting-Chang Chang, Keiko Yamamoto, Shirong Han, Jodi-Ann Mckenzie, Robert J Orlowski, Takuma Miura, Vicky Makker, Yong Man Kim
Analysis of East Asia subgroup in Study 309/KEYNOTE-775: lenvatinib plus pembrolizumab versus treatment of physician's choice chemotherapy in patients with previously treated advanced or recurrent endometrial cancer. Journal of gynecologic oncology 35 (2) (2024)
Nicolás Gómez-Banoy, Eduardo Ortiz, Caroline S Jiang, Christian Dagher, Carlo Sevilla, Jeffrey Girshman, Andrew Pagano, Andrew J Plodkowski, William A Zammarrelli, Jennifer J Mueller, Carol Aghajanian, Jorge S Reis-Filho, Vicky Makker, Paul Cohen, Juan C Osorio
Body mass index and adiposity influence responses to immune checkpoint inhibition in endometrial cancer. medRxiv : the preprint server for health sciences (2024)
Vicky Makker, Matthew H Taylor, Carol Aghajanian, Allen L Cohn, Marcia S Brose, Christopher Di Simone, Zhu Alexander Cao, Leah Suttner, Andrey Loboda, Razvan Cristescu, Petar Jelinic, Robert Orlowski, Lea Dutta, Junji Matsui, Corina E Dutcus, Yukinori Minoshima, Mark J Messing
Evaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: results from Study 111/KEYNOTE-146. Journal for immunotherapy of cancer 12 (1) (2024)
Nicolás Gómez-Banoy, Eduardo Ortiz, Caroline S Jiang, Christian Dagher, Carlo Sevilla, Jeffrey Girshman, Andrew Pagano, Andrew J Plodkowski, William A Zammarrelli, Jennifer J Mueller, Carol Aghajanian, Jorge S Reis-Filho, Vicky Makker, Paul Cohen, Juan C Osorio
Body mass index and adiposity influence responses to immune checkpoint inhibition in endometrial cancer. medRxiv : the preprint server for health sciences (2024)
Kan Yonemori, Keiichi Fujiwara, Kosei Hasegawa, Mayu Yunokawa, Kimio Ushijma, Shiro Suzuki, Ayumi Shikama, Shinichiro Minobe, Tomoka Usami, Jae-Weon Kim, Byoung Gie Kim, Peng-Hui Wang, Ting-Chang Chang, Keiko Yamamoto, Shirong Han, Jodi-Ann Mckenzie, Robert J Orlowski, Takuma Miura, Vicky Makker, Yong Man Kim
Analysis of East Asia subgroup in Study 309/KEYNOTE-775: lenvatinib plus pembrolizumab versus treatment of physician's choice chemotherapy in patients with previously treated advanced or recurrent endometrial cancer. Journal of gynecologic oncology 35 (2) (2024)
Nicolás Gómez-Banoy, Eduardo Ortiz, Caroline S Jiang, Christian Dagher, Carlo Sevilla, Jeffrey Girshman, Andrew Pagano, Andrew J Plodkowski, William A Zammarrelli, Jennifer J Mueller, Carol Aghajanian, Jorge S Reis-Filho, Vicky Makker, Paul Cohen, Juan C Osorio
Body mass index and adiposity influence responses to immune checkpoint inhibition in endometrial cancer. medRxiv : the preprint server for health sciences (2024)
Kan Yonemori, Keiichi Fujiwara, Kosei Hasegawa, Mayu Yunokawa, Kimio Ushijma, Shiro Suzuki, Ayumi Shikama, Shinichiro Minobe, Tomoka Usami, Jae-Weon Kim, Byoung Gie Kim, Peng-Hui Wang, Ting-Chang Chang, Keiko Yamamoto, Shirong Han, Jodi-Ann Mckenzie, Robert J Orlowski, Takuma Miura, Vicky Makker, Yong Man Kim
Analysis of East Asia Subgroup in Study 309/KEYNOTE-775: Lenvatinib plus pembrolizumab versus treatment of physician's choice chemotherapy in patients with previously treated advanced or recurrent endometrial cancer. Journal of gynecologic oncology (2024)
Vicky Makker, Carol Aghajanian, Allen L Cohn, Margarita Romeo Marin, Raquel Bratos, Marcia S Brose, Mark Messing, Lea Dutta, Corina E Dutcus, Jie Huang, Emmett V Schmidt, Robert Orlowski, Matthew H Taylor
A Phase Ib/II Study of Lenvatinib and Pembrolizumab in Advanced Endometrial Carcinoma (Study 111/KEYNOTE-146): Long-Term Efficacy and Safety Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (5) (2023)
Vicky Makker, Nicoletta Colombo, Antonio Casado Herráez, Bradley J Monk, Helen Mackay, Alessandro D Santin, David Scott Miller, Richard G Moore, Sally Baron-Hay, Isabelle L Ray-Coquard, Kimio Ushijma, Kan Yonemori, Yong Man Kim, Eva M Guerra Alia, Ulus A Sanli, Steven Bird, Robert Orlowski, Jodi-Ann Mckenzie, Chinyere E Okpara, Gianmaria Barresi, Domenica Lorusso
Lenvatinib Plus Pembrolizumab in Previously Treated Advanced Endometrial Cancer: Updated Efficacy and Safety From the Randomized Phase III Study 309/KEYNOTE-775. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Ying L Liu, Sushmita Gordhandas, Kanika S Arora, Eric V Rios-Doria, Karen A Cadoo, Amanda Catchings, Anna Maio, Yelena Kemel, Margaret Sheehan, Erin Salo-Mullen, Qin Zhou, Alexia Iasonos, Jian Carrot-Zhang, Beryl Manning-Geist, Tiffany Y Sia, Pier Selenica, Chad Vanderbilt, Maksym Misyura, Alicia J Latham, Chaitanya Bandlamudi, Michael F Berger, Jada G Hamilton, Vicky Makker, Nadeem R Abu-Rustum, Lora H Ellenson, Kenneth Offit, Diana L Mandelker, Zsofia Stadler, Jorge S Reis-Filho, Carol Aghajanian, Carol Brown
Pathogenic germline variants in patients with endometrial cancer of diverse ancestry. Cancer (2023)
Vicky Makker, Carol Aghajanian, Allen L Cohn, Margarita Romeo Marin, Raquel Bratos, Marcia S Brose, Mark Messing, Lea Dutta, Corina E Dutcus, Jie Huang, Emmett V Schmidt, Robert Orlowski, Matthew H Taylor
A Phase Ib/II Study of Lenvatinib and Pembrolizumab in Advanced Endometrial Carcinoma (Study 111/KEYNOTE-146): Long-Term Efficacy and Safety Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (5) (2023)
Ignace Vergote, José Alejandro Pérez-Fidalgo, Erika Paige Hamilton, Giorgio Valabrega, Toon Van Gorp, Jalid Sehouli, David Cibula, Tally Levy, Stephen Welch, Debra L Richardson, Eva M Guerra, Giovanni Scambia, Stéphanie Henry, Pauline Wimberger, David Scott Miller, Jaroslav Klat, Jerónimo Martínez-Garcia, Francesco Raspagliesi, Bhavana Pothuri, Ignacio Romero, Alice Bergamini, Brian Slomovitz, Fabienne Schochter, Estrid Høgdall, Lorena Fariñas-Madrid, Bradley J Monk, Dayana Michel, Michael G Kauffman, Sharon Shacham, Mansoor Raza Mirza, Vicky Makker, null null
Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Vicky Makker, Carol Aghajanian, Allen L Cohn, Margarita Romeo Marin, Raquel Bratos, Marcia S Brose, Mark Messing, Lea Dutta, Corina E Dutcus, Jie Huang, Emmett V Schmidt, Robert Orlowski, Matthew H Taylor
A Phase Ib/II Study of Lenvatinib and Pembrolizumab in Advanced Endometrial Carcinoma (Study 111/KEYNOTE-146): Long-Term Efficacy and Safety Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Vicky Makker, Carol Aghajanian, Allen L Cohn, Margarita Romeo Marin, Raquel Bratos, Marcia S Brose, Mark Messing, Lea Dutta, Corina E Dutcus, Jie Huang, Emmett V Schmidt, Robert Orlowski, Matthew H Taylor
A Phase Ib/II Study of Lenvatinib and Pembrolizumab in Advanced Endometrial Carcinoma (Study 111/KEYNOTE-146): Long-Term Efficacy and Safety Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (5) (2023)
Vicky Makker, Carol Aghajanian, Allen L Cohn, Margarita Romeo Marin, Raquel Bratos, Marcia S Brose, Mark Messing, Lea Dutta, Corina E Dutcus, Jie Huang, Emmett V Schmidt, Robert Orlowski, Matthew H Taylor
A Phase Ib/II Study of Lenvatinib and Pembrolizumab in Advanced Endometrial Carcinoma (Study 111/KEYNOTE-146): Long-Term Efficacy and Safety Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (5) (2023)
Funda Meric-Bernstam, Vicky Makker, Ana Oaknin, Do Youn Oh, Susana Banerjee, Antonio Gonzáles Martin, Kyung Hae Jung, Iwona Ługowska, Luis Manso Sanchez, Aránzazu Manzano, Bohuslav Melichar, Salvatore Siena, Daniil Stroyakovskiy, Anitra Fielding, Yan Ma, Soham Puvvada, Norah Shire, Jung-Yun Lee
Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
William A Zammarrelli, Sarah H Kim, Arnaud Da Cruz Paula, Eric V Rios-Doria, Sarah Ehmann, Effi Yeoshoua, Etta J Hanlon, Qin C Zhou, Alexia E Iasonos, Kaled M Alektiar, Carol Aghajanian, Vicky Makker, Mario L Leitao, Nadeem R Abu-Rustum, Lora H Ellenson, Jorge S Reis-Filho, Jennifer J Mueller
Risk Stratification of Stage I Grade 3 Endometrioid Endometrial Carcinoma in the Era of Molecular Classification. JCO precision oncology 6 (2022)
Anastasia Navitski, Duaa H Al-Rawi, Vicky Makker, Jorge S Reis-Filho, Dmitriy Zamarin, Ying L Liu, Angela G Arnold, Michael Herman Chui, Diana L Mandelker, Michael F Walsh, Deborah F DeLair, Karen A Cadoo, Roisin E O'Cearbhaill
Germline <i>SMARCA4</i> Deletion as a Driver of Uterine Cancer: An Atypical Presentation. JCO precision oncology 6 (2022)
Lea A Moukarzel, Lorenzo Ferrando, Anthe Stylianou, Stephanie Lobaugh, Michelle Wu, Silvana Pedra Nobre, Alexia Iasonos, Gabriele Zoppoli, Dilip D Giri, Nadeem R Abu-Rustum, Vance A Broach, Neil M Iyengar, Jorge S Reis-Filho, Vicky Makker
Impact of obesity and white adipose tissue inflammation on the omental microenvironment in endometrial cancer. Cancer 128 (18) (2022)
Vicky Makker, Matthew H Taylor, Ana Oaknin, Antonio Casado Herraez, Robert Orlowski, Lea Dutta, Min Ren, Melissa Zale, David M O'Malley
Characterization and Management of Adverse Reactions in Patients with Advanced Endometrial Carcinoma Treated with Lenvatinib Plus Pembrolizumab. The oncologist 26 (9) (2021)
Vicky Makker, Helen MacKay, Isabelle L Ray-Coquard, Douglas A Levine, Shannon Neville Westin, Daisuke Aoki, Ana Oaknin
Endometrial cancer. Nature reviews. Disease primers 7 (1) (2021)
Oliver Zivanovic, Dennis S Chi, Qin Zhou, Alexia E Iasonos, Jason A Konner, Vicky Makker, Rachel N Grisham, Amy K Brown, Stacy Nerenstone, John P Diaz, Eric D Schroeder, Carrie L Langstraat, Viktoriya Paroder, Yulia Lakhman, Krysten Soldan, Katy Su, Ginger J Gardner, Vaagn Andikyan, Jianxia Guo, Elizabeth L Jewell, Kara Long Roche, Tiffany Troso-Sandoval, Stuart M Lichtman, Lea A Moukarzel, Kimberly Dessources, Nadeem R Abu-Rustum, Carol Aghajanian, William P Tew, Jan H Beumer, Yukio Sonoda, Roisin E O'Cearbhaill
Secondary Cytoreduction and Carboplatin Hyperthermic Intraperitoneal Chemotherapy for Platinum-Sensitive Recurrent Ovarian Cancer: An MSK Team Ovary Phase II Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (23) (2021)